Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Perreau

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Viruses|May 28, 2022
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19Antonios Kritikos, Sophie Gabellon, Jean-Luc Pagani, et al.
JCI Insight|October 28, 2025
Viral reservoir characteristics in lymphoid tissues of HIV-1 elite controllersSamantha K Marzi, Chloé M Naasz, Leah Carrere, et al.
The Journal of Clinical Investigation|August 28, 2018
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirsLiang Cheng, Qi Wang, Guangming Li, et al.
Plos Pathogens|July 16, 2013
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cellsSelena Viganò, Felicitas Bellutti Enders, Isabelle Miconnet, et al.
Journal of Virology|April 12, 2012
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesMatthieu Perreau, Hugh C Welles, Celine Pellaton, et al.
Plos Pathogens|July 23, 2019
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagementRiddhima Banga, Caterina Rebecchini, Francesco Andrea Procopio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
The Journal of Infectious Diseases|April 3, 2020
Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral TherapyHsiao-Hsuan Kuo, Riddhima Banga, Guinevere Q Lee, et al.
European Journal of Immunology|February 26, 2013
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active diseaseMatthieu Perreau, Virginie Rozot, Hugh C Welles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged PatientsIrene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Viruses|May 28, 2022
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19Antonios Kritikos, Sophie Gabellon, Jean-Luc Pagani, et al.
JCI Insight|October 28, 2025
Viral reservoir characteristics in lymphoid tissues of HIV-1 elite controllersSamantha K Marzi, Chloé M Naasz, Leah Carrere, et al.
The Journal of Clinical Investigation|August 28, 2018
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirsLiang Cheng, Qi Wang, Guangming Li, et al.
Plos Pathogens|July 16, 2013
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cellsSelena Viganò, Felicitas Bellutti Enders, Isabelle Miconnet, et al.
Journal of Virology|April 12, 2012
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesMatthieu Perreau, Hugh C Welles, Celine Pellaton, et al.
Plos Pathogens|July 23, 2019
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagementRiddhima Banga, Caterina Rebecchini, Francesco Andrea Procopio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
The Journal of Infectious Diseases|April 3, 2020
Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral TherapyHsiao-Hsuan Kuo, Riddhima Banga, Guinevere Q Lee, et al.
European Journal of Immunology|February 26, 2013
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active diseaseMatthieu Perreau, Virginie Rozot, Hugh C Welles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged PatientsIrene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Pageof 12